Dr. John Glod, MD
Claim this profileNational Cancer Institute Pediatric Oncology Branch
Studies Cerebral Gliomas
Studies Soft Tissue Sarcoma
10 reported clinical trials
13 drugs studied
Area of expertise
1Cerebral Gliomas
Stage IV
H3K27M positive
Stage III
2Soft Tissue Sarcoma
Stage IV
HLA-A positive
MAGE-A4 positive
Affiliated Hospitals
Clinical Trials John Glod, MD is currently running
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
Afamitresgene Autoleucel
for Pediatric Cancer
This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-21 years of age with advanced cancers
Recruiting1 award Phase 1 & 2
More about John Glod, MD
Clinical Trial Related8 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John Glod, MD has experience with
- Ivosidenib
- Tipifarnib
- Selpercatinib
- Hydroxychloroquine
- Dabrafenib
- Trametinib
Breakdown of trials John Glod, MD has run
Cerebral Gliomas
Soft Tissue Sarcoma
Brain Tumor
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Glod, MD specialize in?
John Glod, MD focuses on Cerebral Gliomas and Soft Tissue Sarcoma. In particular, much of their work with Cerebral Gliomas has involved Stage IV patients, or patients who are H3K27M positive.
Is John Glod, MD currently recruiting for clinical trials?
Yes, John Glod, MD is currently recruiting for 2 clinical trials in Bethesda Maryland. If you're interested in participating, you should apply.
Are there any treatments that John Glod, MD has studied deeply?
Yes, John Glod, MD has studied treatments such as Ivosidenib, Tipifarnib, Selpercatinib.
What is the best way to schedule an appointment with John Glod, MD?
Apply for one of the trials that John Glod, MD is conducting.
What is the office address of John Glod, MD?
The office of John Glod, MD is located at: National Cancer Institute Pediatric Oncology Branch, Bethesda, Maryland 20892 United States. This is the address for their practice at the National Cancer Institute Pediatric Oncology Branch.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.